Ex Parte CARCASONA et al - Page 4




              Appeal No. 2001-1947                                                                                        
              Application 08/333,202                                                                                      
              the claimed subject matter to a person of ordinary skill in the art.  In re Bell, 991 F.2d                  
              781, 783, 26 USPQ2d 1529, 1531 (Fed. Cir. 1993).  An obviousness analysis requires                          
              that the prior art both suggest the claimed subject matter and reveal a reasonable                          
              expectation of success to one reasonably skilled in the art.  In re Vaeck, 947 F.2d 488,                    
              493, 20 USPQ2d 1438, 1442 (Fed. Cir. 1993).                                                                 
                     It is the examiner=s position that (Answer, page 4):                                                 
                     The claims are product-by-process claims drawn to the compound                                       
                     diacetylrhein. . . .  Friedmann teaches the compound diacetylrhein and its                           
                     use for the treatment of arthritis. . . .  The compound taught by Friedmann                          
                     would inherently be substantially pure, essentially free from aloe-emodin                            
                     derivatives.                                                                                         
                     According to the examiner, “[t]here is no apparent difference in the com-  pounds.                   
              . . .   To the extent that the purity of the compound of the reference and that of                          
              the claims differ, the claims are rejected under 35 U.S.C. ' 103(a)”  (Answer, page 4) .                    
              Merck also teaches the compound diacetylrhein and its use as an antirheumatic.  The                         
              examiner argues there is no apparent difference between the claimed compound and                            
              the Merck compound.  Id.                                                                                    
                     With respect to claim 22, the examiner finds that the composition of claim 22                        
              reads on a water solution of the diacetylrhein compound, citing Friedmann, column 8,                        
              lines 35 and 54 and Merck Index, Abstract 8072, page 1179.   Answer, page 4.                                






                                                            4                                                             





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007